170 related articles for article (PubMed ID: 2436223)
1. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Jarrett RF; Matsukura M; Di Marzo Veronese F; DeVico AL; Sarngadharan MG; Johns DG; Reitz MS; Broder S
Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2033-7. PubMed ID: 2436223
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
Mitsuya H; Broder S
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1911-5. PubMed ID: 3006077
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Broder S
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
[TBL] [Abstract][Full Text] [Related]
4. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Richman DD; Kornbluth RS; Carson DA
J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.
Haertle T; Carrera CJ; Wasson DB; Sowers LC; Richman DD; Carson DA
J Biol Chem; 1988 Apr; 263(12):5870-5. PubMed ID: 3258602
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
7. 2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
Johnson MA; Johns DG; Fridland A
Biochem Biophys Res Commun; 1987 Nov; 148(3):1252-8. PubMed ID: 2825680
[TBL] [Abstract][Full Text] [Related]
8. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
Balzarini J; Pauwels R; Baba M; Robins MJ; Zou RM; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 May; 145(1):269-76. PubMed ID: 3496089
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.
Matsushita S; Mitsuya H; Reitz MS; Broder S
J Clin Invest; 1987 Aug; 80(2):394-400. PubMed ID: 3038956
[TBL] [Abstract][Full Text] [Related]
10. The 2',3'-dideoxyriboside of 2,6-diaminopurine and its 2',3'-didehydro derivative inhibit the deamination of 2',3'-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication.
Balzarini J; Robins MJ; Zou RM; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 May; 145(1):277-83. PubMed ID: 3496090
[TBL] [Abstract][Full Text] [Related]
11. Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro.
Tsai CC; Follis KE; Benveniste RE
AIDS Res Hum Retroviruses; 1988 Oct; 4(5):359-68. PubMed ID: 2461724
[TBL] [Abstract][Full Text] [Related]
12. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
[TBL] [Abstract][Full Text] [Related]
13. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
14. Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside.
Pauwels R; Baba M; Balzarini J; Herdewijn P; Desmyter J; Robins MJ; Zou RM; Madej D; De Clercq E
Biochem Pharmacol; 1988 Apr; 37(7):1317-25. PubMed ID: 3258516
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of the 2-chloro analogues of 3'-deoxyadenosine, 2',3'-dideoxyadenosine, and 2',3'-didehydro-2',3'-dideoxyadenosine as potential antiviral agents.
Rosowsky A; Solan VC; Sodroski JG; Ruprecht RM
J Med Chem; 1989 May; 32(5):1135-40. PubMed ID: 2785212
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of 2',3'-dideoxycytidine: an inhibitor of human immunodeficiency virus.
Broder S
Am J Med; 1990 May; 88(5B):2S-7S. PubMed ID: 1692446
[TBL] [Abstract][Full Text] [Related]
17. Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes.
Carson DA; Haertle T; Wasson DB; Richman DD
Biochem Biophys Res Commun; 1988 Mar; 151(2):788-93. PubMed ID: 3258154
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
Kierdaszuk B; Bohman C; Ullman B; Eriksson S
Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2',3'-dideoxynucleosides by enzymatic trans-glycosylation.
Carson DA; Wasson DB
Biochem Biophys Res Commun; 1988 Sep; 155(2):829-34. PubMed ID: 3262341
[TBL] [Abstract][Full Text] [Related]
20. Uptake of 2',3'-dideoxyadenosine in human immunodeficiency virus-infected and noninfected human cells.
Agarwal RP; Busso ME; Mian AM; Resnick L
AIDS Res Hum Retroviruses; 1989 Oct; 5(5):541-50. PubMed ID: 2590557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
